Japanese encephalitis vaccine (Shandong Hengye Biotech)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameJapanese encephalitis vaccine (Shandong Hengye Biotech)
Drug Alias Name流行性乙型脑炎疫苗 - 山东恒业生物技术有限公司Vero cell-derived inactivated Japanese encephalitis vaccine日本脑炎疫苗 - 山东恒业生物技术有限公司
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsEncephalitis, Viral
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaPending
Originator CompaniesShandong Hengye Biotech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShandong Hengye Biotech Co Ltd
Active IndicationsN/A
Inactive IndicationsEncephalitis, Viral

Other Information

ATC CodeN/A
Related LinksN/A